CLINICAL_TRIALS
trial_result
· 2019-04-02
Clinical Trial Update: A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer [Phase 2]
Summary
Phase 2 trial update examining ABT-888 in combination with Temozolomide for colorectal cancer has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Georgetown University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-04-02